BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6221603)

  • 1. Possible involvement of phospholipase A2 activation and lipoxygenase product(s) in the mechanism of insulin secretion.
    Kato R; Yamamoto S; Nakadate T; Nakaki T
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():265-70. PubMed ID: 6221603
    [No Abstract]   [Full Text] [Related]  

  • 2. Pancreatic islet phospholipase A2: differential, Ca2+-dependent effects of lysophospholipids, arachidonic acid, and its lipoxygenase-derived metabolites on insulin release.
    Metz SA
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():668-76. PubMed ID: 2960174
    [No Abstract]   [Full Text] [Related]  

  • 3. Is type IV phospholipase A2 involved in the regulation of insulin secretion?
    Parker KJ; Howell SL; Jones PM
    Biochem Soc Trans; 1997 May; 25(2):213S. PubMed ID: 9191257
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor promotor 12-O-tetradecanoylphorbol-13-acetate-induced insulin secretion: inhibition by phospholipase A2-and lipoxygenase-inhibitors.
    Yamamoto S; Nakadate T; Nakaki T; Ishii K; Kato R
    Biochem Biophys Res Commun; 1982 Mar; 105(2):759-65. PubMed ID: 6807307
    [No Abstract]   [Full Text] [Related]  

  • 5. Ether-linked lysophospholipids initiate insulin secretion. Lysophospholipids may mediate effects of phospholipase A2 activation on hormone release.
    Metz SA
    Diabetes; 1986 Jul; 35(7):808-17. PubMed ID: 3087803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phasic effects of glucose, phospholipase A2, and lysophospholipids on insulin secretion.
    Fujimoto WY; Metz SA
    Endocrinology; 1987 May; 120(5):1750-7. PubMed ID: 3552622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of glucose-induced insulin secretion by lipoxygenase inhibitor.
    Yamamoto S; Nakadate T; Nakaki T; Ishii K; Kato R
    Eur J Pharmacol; 1982 Feb; 78(2):225-7. PubMed ID: 6804249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A specific inhibitor of cytosolic phospholipase A2 activity, AACOCF3, inhibits glucose-induced insulin secretion from isolated rat islets.
    Loweth AC; Scarpello JH; Morgan NG
    Biochem Biophys Res Commun; 1996 Jan; 218(2):423-7. PubMed ID: 8561771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanism by which melittin stimulates insulin secretion from isolated rat islets of Langerhans.
    Morgan NG; Rumford GM; Montague W
    Biochim Biophys Acta; 1985 Jun; 845(3):526-32. PubMed ID: 3924121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of exogenous phospholipase A2 on insulin secretion from perifused rat islets.
    Zawalich W; Zawalich K
    Diabetes; 1985 May; 34(5):471-6. PubMed ID: 3921420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of phospholipase A2 and arachidonic acid in cholecystokinin-8-induced insulin secretion in rat islets.
    Simonsson E; Karlsson S; Ahrén B
    Regul Pept; 1996 Sep; 65(2):101-7. PubMed ID: 8884976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbachol stimulation of phospholipase A2 and insulin secretion in pancreatic islets.
    Konrad RJ; Jolly YC; Major C; Wolf BA
    Biochem J; 1992 Oct; 287 ( Pt 1)(Pt 1):283-90. PubMed ID: 1417779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Starvation decreases insulin secretion, prostaglandin E2 production and phospholipase A2 activity in rat pancreatic islets.
    Tadayyon M; Bonney RC; Green IC
    J Endocrinol; 1990 Mar; 124(3):455-61. PubMed ID: 2185328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for lipoxygenase mediation of arachidonic acid-stimulated insulin secretion.
    Metz SA; Little S; Fujimoto W; Robertson RP
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():271-7. PubMed ID: 6221604
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulinotropic effects of exogenous phospholipase A2 and C in isolated pancreatic islets.
    Yamamoto S; Nakaki T; Nakadate T; Kato R
    Eur J Pharmacol; 1982 Dec; 86(1):121-4. PubMed ID: 6819152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of phospholipase A2 and insulin secretion in pancreatic islets.
    Konrad RJ; Jolly YC; Major C; Wolf BA
    Biochim Biophys Acta; 1992 Jun; 1135(2):215-20. PubMed ID: 1616940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of insulin secretion by lipoxygenase products of arachidonic acid. Relation to lipoxygenase activity of pancreatic islets.
    Yamamoto S; Ishii M; Nakadate T; Nakaki T; Kato R
    J Biol Chem; 1983 Oct; 258(20):12149-52. PubMed ID: 6415050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of specificity of melittin as a probe for insulin release mediated by endogenous phospholipase A2 or lipoxygenase.
    Metz SA
    Biochem Pharmacol; 1986 Oct; 35(19):3371-81. PubMed ID: 3094540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient activation of calcium-dependent phospholipase A2 by insulin secretagogues in isolated pancreatic islets.
    Jolly YC; Major C; Wolf BA
    Biochemistry; 1993 Nov; 32(45):12209-17. PubMed ID: 8218298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation by glucose and carbamylcholine of phospholipase A2 in pancreatic islets.
    Mathias PC; Best L; Malaisse WJ
    Diabetes Res; 1985 Sep; 2(5):267-70. PubMed ID: 3933882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.